MDG Medical

company

About

MDG Medical provider of an automated pharmaceutical dispensing system for use in hospitals.

  • 51 - 100

Details

Last Funding Type
Series B
Last Funding Money Raised
$7.50M
Industries
Biotechnology,Health Care,Medical
Founded date
Jan 1, 2000
Number Of Employee
51 - 100
Operating Status
Active

MDG Medical developed the affordable and cost-effective ServeRx® system for hospitals and long-term-care settings to reduce medication errors, improve management of medications and enhance patient safety. ServeRx® produces rapid return on investment as health-care institutions may quickly recognize thousands or millions of dollars of cost savings.

Thousands of people die and tens of thousands more are injured each year due to preventable medication errors. These errors, including patient mixups, illegible prescriptions, confusion between different pharmaceuticals with similar names, and incorrect dosages, cause deep human suffering. For health-care institutions, preventable medication errors lengthen patients' hospital stays and create millions of dollars of additional operating expenses and liability costs.

Adverse drug events (ADEs) occur at a rate of 2.5% of hospital admissions in the U.S. and 10% in Europe. Each of these ADEs costs hospitals an average of nearly $5,000. Worldwide, legislators and the public at large are demanding that health-care institutions take affirmative steps to better manage their medication efforts and protect their patients.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$7.50M
MDG Medical has raised a total of $7.50M in funding over 2 rounds. Their latest funding was raised on Feb 13, 2004 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 13, 2004 Series B $7.50M 2 Detail

Investors

Number of Lead Investors
Number of Investors
2
MDG Medical is funded by 2 investors. LSKW Investments LP and RSL Venture Partners are the most recent investors.
Investor Name Lead Investor Funding Round
LSKW Investments LP Series B
RSL Venture Partners Series B